客户发表文献

论文在线提交

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

开始时间
页码: 186/5127 每页显示数量
Structural basis of Gabija anti-phage defence and viral immune evasion
Authors: Sadie P Antine, Alex G Johnson, Sarah E Mooney, Azita Leavitt, Megan L Mayer, Erez Yirmiya, Gil Amitai, Rotem Sorek, Philip J Kranzusch
Journal: Nature
PubMed ID: 37992757
Doi: 10.1038/s41586-023-06855-2
Products & Services: Gene Synthesis   
A synthetic differentiation circuit in Escherichia coli for suppressing mutant takeover
Authors: David S Glass 1, Anat Bren 2, Elizabeth Vaisbourd 2, Avi Mayo 2, Uri Alon
Journal: Cell
PubMed ID: 38320549
Doi: 10.1016/j.cell.2024.01.024
Products & Services: Plasmid DNA Preparation   
Sirtuin 3 is required for the dexmedetomidine-mediated alleviation of inflammation and oxidative stress in nephritis
Authors: Kai Lu , Xinlong Li , Jie Wu
Journal: Immunity
PubMed ID: 38270316
Doi: 10.1002/iid3.1135
Products & Services: Custom DNA/RNA Oligos   
9S1R nullomer peptide induces mitochondrial pathology, metabolic suppression, and enhanced immune cell infiltration, in triple-negative breast cancer mouse model
Authors: Nilufar Ali, Cody Wolf, Swarna Kanchan, Shivakumar R Veerabhadraiah, Laura Bond, Matthew W Turner, Cheryl L Jorcyk, Greg Hampikian
Journal: Biomed Pharmacother
PubMed ID: 38118350
Doi: 10.1016/j.biopha.2023.115997.
Products & Services: Peptide Synthesis   
Redox signalling regulates breast cancer metastasis via phenotypic and metabolic reprogramming due to p63 activation by HIF1α
Authors: Zuen Ren, Malindrie Dharmaratne, Huizhi Liang, Outhiriaradjou Benard, Miriam Morales-Gallego, Kimita Suyama, Viney Kumar, Atefeh Taherian Fard, Ameya S Kulkarni, Michael Prystowsky, Jessica C Mar, Larry Norton, Rachel B Hazan
Journal: Br J Cancer
PubMed ID: 38238426
Doi: 10.1038/s41416-023-02522-5
Products & Services: ORF cDNA Clones/MolecularCloud   
Revamped mini-αA-crystallin showed improved skin permeation and therapeutic activity against melittin-induced toxicity
Authors: Tenzin Tender, Rakesh Ravishankar Rahangdale, Madhavan Nampoothiri, Ruchira Raychaudhuri, Srinivas Mutalik, Krishna Sharma, Raghu Chandrashekar H
Journal: Toxicon
PubMed ID: 38211805
Doi: 10.1016/j.toxicon.2024.107611
Products & Services: Gene Synthesis   
Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity
Authors: Miguel Á Muñoz-Alía, Rebecca A Nace, Baskar Balakrishnan, Lianwen Zhang, Nandakumar Packiriswamy, Gagandeep Singh, Prajakta Warang, Ignacio Mena, Riya Narjari, Rianna Vandergaast, Kah-Whye Peng, Adolfo García-Sastre, Michael Schotsaert, Stephen J Russell
Journal: MBio
PubMed ID: 38193729
Doi: 10.1128/mbio.02928-23
Products & Services: Gene Synthesis   
Production of recombinant HPV11/16 E6/E7-MBP-His fusion proteins and their potential to induce cytokine secretion by immune cells in peripheral blood
Authors: Mei-Nian Xu, Mei-Zhen Zhong, Si-Ning Feng, Yan-Qin Xu, Xiao-Ming Peng, Kang Zeng, Xiao-Wen Huang
Journal: Virol J
PubMed ID: 38183109
Doi: 10.1186/s12985-023-02281-y
Products & Services: Molecular Biology Reagents   
Development of Moloney Murine Leukemia Virus Reverse Transcriptase Fused with Archaeal DNA-binding Protein Sis7a
Authors: Goldyna M Simanjuntak, Azzania Fibriani, Amalia A Fananda, Nicholas Yamahoki
Journal: Recent Pat Biotechnol
PubMed ID: 37016518
Doi: 10.2174/1872208317666230403104302
Products & Services: Custom Vector Construction   
Inactivation mechanism of cold plasma combined with 222 nm ultraviolet for spike protein and its application in disinfecting of SARS-CoV-2
Authors: Xiaowei Sheng, Jin Wang, Luling Zhao, Wenjing Yan, Jing Qian, Zhaobin Wang, Jianhao Zhang, Vijaya Raghavan
Journal: J Hazard Mater
PubMed ID: 38215522
Doi: 10.1016/j.jhazmat.2024.133458
Products & Services: Molecular Biology Reagents   

喜欢新升级的网站吗?

讨厌

不喜欢

一般

喜欢

非常喜欢

*